Meeting Register Page

Meeting banner
Psychedelic Research for End-of Life Existential Distress
This presentation will review the history and scientific findings from psychedelic and mystical experience research highlighting the treatment of psychological, existential, and spiritual distress in palliative care and at the end of life. Implications for the future of palliative and hospice care will be addressed.

Bio :
Anthony P. Bossis, Ph.D. is a clinical assistant professor of psychiatry at the NYU Grossman School of Medicine and the NYU Center for Psychedelic Medicine conducting research with psilocybin since 2009. Dr. Bossis was director of palliative care research and co-principal investigator on the clinical psilocybin trial demonstrating a rapid and sustained reduction in psychological distress and improvements in existential well-being in cancer patients. He is study director and lead session guide on a clinical trial evaluating psilocybin-generated mystical experience upon religious leaders. Dr. Bossis is a training supervisor of psychotherapy at NYU-Bellevue Hospital Center and co-founder of the Bellevue Hospital Palliative Care Service.. His psilocybin research interests include the treatment of end-of-life distress, myriad mental health disorders, and advancing our understanding of consciousness, meaning, and spirituality. He maintains a consulting and psychotherapy practice in NYC.

Hosted by the Stanford Psychedelic Science Group:

Jun 7, 2021 05:00 PM in Pacific Time (US and Canada)

* Required information